Wealth Enhancement Advisory Services, LLC Immunome Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Immunome Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 53,187 shares of IMNM stock, worth $455,280. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53,187
Previous 51,544
3.19%
Holding current value
$455,280
Previous $346,000
42.77%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding IMNM
# of Institutions
147Shares Held
66.4MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$64.7 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$45.9 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$37.3 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$36.9 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$34.9 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $104M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...